Literature DB >> 23461789

Quality of life in children treated with restrictive diet for inherited metabolic disease.

Tuba F Eminoglu1, Sebnem A Soysal, Leyla Tumer, Ilyas Okur, Alev Hasanoglu.   

Abstract

BACKGROUND: The aim of this study was to investigate the quality of life (QoL) of a group of patients with inherited metabolic diseases (IMD) who were treated with restrictive diet.
METHOD: A total of 68 patients (35 boys, 51.5%; 33 girls, 48.5%) with IMD (organic acidemia [OA], n = 14; disorder of carbohydrate metabolism [CMD], n = 33; and disorder of amino acid metabolism [AMD], n = 21) and their parents were inteviewed. Both parents completed a QoL Scale for Metabolic Diseases-Parent Form, a KINDL parent questionnaire, and a depression form. All patients aged ≥4 years completed a questionnaire themselves, including the KINDL-Kid and KINDL-Kiddo self-reports. The semi-standardized interviews were carried out with patients and their parents in a clinical setting.
RESULTS: The patients with bad diet compliance had lower scores for school labeling and perception of disease on both the parent and child questionnaire forms (P < 0.05). The patients were then divided into three groups (OA, CMD, AMD) for further analysis. Differences were seen between groups with regard to scores of physical function and school performance according to QoL Scale for Metabolic Diseases-Parent Form (P < 0.01). According to parent perceptions, the CMD patients had better QoL with regard to emotional wellbeing.
CONCLUSION: As negative effects of the disease increased, the QoL of IMD patients and their parents decreased in terms of emotional, physical, and cognitive function. Application of expanded newborn scanning programs, early diagnosis, regular follow up, and family education would lessen the effects of the disease and improve the QoL of both families and children.
© 2013 The Authors. Pediatrics International © 2013 Japan Pediatric Society.

Entities:  

Keywords:  children; diet treatment; inherited metabolic disease; quality of life

Mesh:

Year:  2013        PMID: 23461789     DOI: 10.1111/ped.12089

Source DB:  PubMed          Journal:  Pediatr Int        ISSN: 1328-8067            Impact factor:   1.524


  7 in total

1.  Caregiver Quality of Life with Tyrosinemia Type 1.

Authors:  Hailey Campbell; Rani H Singh; Eric Hall; Nadia Ali
Journal:  J Genet Couns       Date:  2017-11-06       Impact factor: 2.537

2.  Difficulties in Daily Life and Associated Factors, and QoL of Children with Inherited Metabolic Disease and Their Parents in Japan: A Literature Review.

Authors:  Keiko Yamaguchi; Rie Wakimizu; Mitsuru Kubota
Journal:  JIMD Rep       Date:  2016-06-26

3.  Impaired Health-Related Quality of Life in Children and Families Affected by Methylmalonic Acidemia.

Authors:  Kimberly Splinter; Anna-Kaisa Niemi; Rachel Cox; Julia Platt; Monisha Shah; Gregory M Enns; Mureo Kasahara; Jonathan A Bernstein
Journal:  J Genet Couns       Date:  2015-12-14       Impact factor: 2.537

Review 4.  Quality of life, psychological adjustment, and adaptive functioning of patients with intoxication-type inborn errors of metabolism - a systematic review.

Authors:  Nina A Zeltner; Martina Huemer; Matthias R Baumgartner; Markus A Landolt
Journal:  Orphanet J Rare Dis       Date:  2014-10-25       Impact factor: 4.123

5.  Key patient-reported outcomes in children and adolescents with intoxication-type inborn errors of metabolism: an international Delphi-based consensus.

Authors:  Martina Huemer; Markus A Landolt; Florin Bösch; Nina A Zeltner; Matthias R Baumgartner
Journal:  Orphanet J Rare Dis       Date:  2022-01-29       Impact factor: 4.123

6.  Depression and anxiety among parents of phenylketonuria children.

Authors:  Mehmet Gunduz; Nur Arslan; Ozlem Unal; Sevim Cakar; Pinar Kuyum; Selda F Bulbul
Journal:  Neurosciences (Riyadh)       Date:  2015-10       Impact factor: 0.906

Review 7.  Patient and observer reported outcome measures to evaluate health-related quality of life in inherited metabolic diseases: a scoping review.

Authors:  Carlota Pascoal; Sandra Brasil; Rita Francisco; Dorinda Marques-da-Silva; Agnes Rafalko; Jaak Jaeken; Paula A Videira; Luísa Barros; Vanessa Dos Reis Ferreira
Journal:  Orphanet J Rare Dis       Date:  2018-11-28       Impact factor: 4.123

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.